{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T01:16:28Z","timestamp":1790212588421,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T00:00:00Z","timestamp":1555977600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Innovation Fund of the Federal Joint Committee of the Federal Republic of Germany","award":["01VSF16003"],"award-info":[{"award-number":["01VSF16003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12872-019-1074-7","type":"journal-article","created":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T16:06:26Z","timestamp":1556035586000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Ischemic stroke risk estimation in patients without oral anticoagulation: an observational cohort study based on secondary data from Germany"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9244-114X","authenticated-orcid":false,"given":"Felix S.","family":"Wicke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin A.","family":"Schaller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kateryna","family":"Karymova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Beyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate S.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,23]]},"reference":[{"issue":"12","key":"1074_CR1","doi-asserted-by":"publisher","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","volume":"146","author":"RG Hart","year":"2007","unstructured":"Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146(12):857\u201367.","journal-title":"Ann Intern Med"},{"key":"1074_CR2","doi-asserted-by":"crossref","unstructured":"Aguilar MI, Hart R. Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks. Cochrane Database Syst Rev 2005; (3):CD001927.","DOI":"10.1002\/14651858.CD001927.pub2"},{"issue":"38","key":"1074_CR3","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","volume":"37","author":"P Kirchhof","year":"2016","unstructured":"Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37(38):2893\u2013962.","journal-title":"Eur Heart J"},{"issue":"23","key":"1074_CR4","first-page":"e199","volume":"130","author":"CT January","year":"2014","unstructured":"January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC, et al. 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines and the Heart Rhythm Society. Circulation. 2014;130(23):e199\u2013267.","journal-title":"Circulation"},{"key":"1074_CR5","doi-asserted-by":"crossref","unstructured":"January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JC, et al. 2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS guideline for the Management of Patients with Atrial Fibrillation. Circulation. 2019:CIR0000000000000665.","DOI":"10.1016\/j.hrthm.2019.01.024"},{"issue":"2","key":"1074_CR6","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1378\/chest.09-1584","volume":"137","author":"GYH Lip","year":"2010","unstructured":"Lip GYH, Nieuwlaat R, Pisters R, Lane DA, Crijns HJGM. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137(2):263\u201372.","journal-title":"Chest"},{"issue":"12","key":"1074_CR7","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1093\/eurheartj\/ehr488","volume":"33","author":"L Friberg","year":"2012","unstructured":"Friberg L, Rosenqvist M, Lip GYH. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish atrial fibrillation cohort study. Eur Heart J. 2012;33(12):1500\u201310.","journal-title":"Eur Heart J"},{"issue":"17","key":"1074_CR8","first-page":"1851","volume":"66","author":"HA Ham van den","year":"2015","unstructured":"van den Ham HA, Klungel OH, Singer DE, Leufkens HGM, van Staa TP. Comparative performance of ATRIA, CHADS2, and CHA2DS2-VASc risk scores predicting stroke in patients with atrial fibrillation. Results From a National Primary Care Database J Am Coll Cardiol. 2015;66(17):1851\u20139.","journal-title":"Results From a National Primary Care Database J Am Coll Cardiol"},{"issue":"11","key":"1074_CR9","doi-asserted-by":"publisher","first-page":"2984","DOI":"10.1161\/STROKEAHA.117.018551","volume":"48","author":"T-H Kim","year":"2017","unstructured":"Kim T-H, Yang P-S, Kim D, Yu HT, Uhm J-S, Kim J-Y, et al. CHA2DS2-VASc score for identifying truly low-risk atrial fibrillation for stroke: a Korean Nationwide cohort study. Stroke. 2017;48(11):2984\u201390.","journal-title":"Stroke"},{"issue":"3","key":"1074_CR10","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.113.000250","volume":"2","author":"DE Singer","year":"2013","unstructured":"Singer DE, Chang Y, Borowsky LH, Fang MC, Pomernacki NK, Udaltsova N, et al. A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score. J Am Heart Assoc. 2013;2(3):e000250.","journal-title":"J Am Heart Assoc"},{"key":"1074_CR11","doi-asserted-by":"publisher","first-page":"d124","DOI":"10.1136\/bmj.d124","volume":"342","author":"JB Olesen","year":"2011","unstructured":"Olesen JB, Lip GYH, Hansen ML, Hansen PR, Tolstrup JS, Lindhardsen J, et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: Nationwide cohort study. BMJ. 2011;342:d124.","journal-title":"BMJ"},{"key":"1074_CR12","doi-asserted-by":"crossref","unstructured":"Allan V, Banerjee A, Shah AD, Patel R, Denaxas S, Casas J-P et al. Net clinical benefit of warfarin in individuals with atrial fibrillation across stroke risk and across primary and secondary care. Heart 2017; 103(3):210\u2013218. Available from: URL: \n                    https:\/\/heart.bmj.com\/content\/103\/3\/210\n                    \n                  .","DOI":"10.1136\/heartjnl-2016-309910"},{"issue":"3","key":"1074_CR13","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1161\/CIRCULATIONAHA.116.024057","volume":"135","author":"GR Quinn","year":"2017","unstructured":"Quinn GR, Severdija ON, Chang Y, Singer DE. Wide variation in reported rates of stroke across cohorts of patients with atrial fibrillation. Circulation. 2017;135(3):208\u201319.","journal-title":"Circulation"},{"key":"1074_CR14","doi-asserted-by":"crossref","unstructured":"Zhou X-H, Obuchowski NA, McClish DK. Statistical methods in diagnostic medicine. 2., Auflage. New York, NY: John Wiley & Sons; 2011. (Wiley Series in Probability and Statistics).","DOI":"10.1002\/9780470906514"},{"key":"1074_CR15","unstructured":"R Core Team. R: A language and environment for statistical computing. Vienna, Austria; 2017. Available from: URL: \n                    https:\/\/www.R-project.org\/\n                    \n                  ."},{"key":"1074_CR16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez J-C, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. 2011;12:77.","journal-title":"BMC Bioinformatics"},{"issue":"5","key":"1074_CR17","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1378\/chest.10-0134","volume":"138","author":"R Pisters","year":"2010","unstructured":"Pisters R, Lane DA, Nieuwlaat R, de VCB, Crijns HJGM, Lip GYH. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the euro heart survey. Chest. 2010;138(5):1093\u2013100.","journal-title":"Chest"},{"issue":"3","key":"1074_CR18","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jacc.2014.10.052","volume":"65","author":"L Friberg","year":"2015","unstructured":"Friberg L, Skeppholm M, Ter\u00e9nt A. Benefit of anticoagulation unlikely in patients with atrial fibrillation and a CHA2DS2-VASc score of 1. J Am Coll Cardiol. 2015;65(3):225\u201332.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"1074_CR19","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1055\/s-0036-1598005","volume":"43","author":"B Bikdeli","year":"2017","unstructured":"Bikdeli B, Abou Ziki MD, Lip GYH. Pulmonary embolism and atrial fibrillation: two sides of the same coin? A systematic review. Semin Thromb Hemost. 2017;43(8):849\u201363.","journal-title":"Semin Thromb Hemost"},{"key":"1074_CR20","first-page":"1181","volume-title":"When atrial fibrillation occurs with pulmonary embolism, is it the chicken or the egg?","author":"KM Flegel","year":"1999","unstructured":"Flegel KM. When atrial fibrillation occurs with pulmonary embolism, is it the chicken or the egg? vol. 160; 1999. p. 1181\u20132."},{"issue":"11","key":"1074_CR21","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1093\/eurheartj\/ehi130","volume":"26","author":"M Ogren","year":"2005","unstructured":"Ogren M, Bergqvist D, Eriksson H, Lindblad B, Sternby NH. Prevalence and risk of pulmonary embolism in patients with intracardiac thrombosis: a population-based study of 23 796 consecutive autopsies. Eur Heart J. 2005;26(11):1108\u201314.","journal-title":"Eur Heart J"},{"issue":"2","key":"1074_CR22","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3324\/haematol.2012.069195","volume":"98","author":"K Langevelde van","year":"2013","unstructured":"van Langevelde K, Sr\u00e1mek A, Vincken PWJ, van Rooden J-K, Rosendaal FR, Cannegieter SC. Finding the origin of pulmonary emboli with a total-body magnetic resonance direct thrombus imaging technique. Haematologica. 2013;98(2):309\u201315.","journal-title":"Haematologica"},{"issue":"10063","key":"1074_CR23","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1016\/S0140-6736(16)30514-1","volume":"388","author":"M Nisio Di","year":"2016","unstructured":"Di Nisio M, van Es N, B\u00fcller HR. Deep vein thrombosis and pulmonary embolism. Lancet. 2016;388(10063):3060\u201373.","journal-title":"Lancet"},{"key":"1074_CR24","unstructured":"Catalogue of bias collaboration, Aronson JK, Bankhead C, Mahtani KR, Nunan D. Confounding by indication. Calaogue Of Biases; 2018 [cited 2018 Nov 13]. Available from: URL: \n                    https:\/\/catalogofbias.org\/biases\/confounding-by-indication\n                    \n                  ."},{"issue":"16","key":"1074_CR25","first-page":"293","volume":"109","author":"RB Schnabel","year":"2012","unstructured":"Schnabel RB, Wilde S, Wild PS, Munzel T, Blankenberg S. Atrial fibrillation: its prevalence and risk factor profile in the German general population. Dtsch Arztebl Int. 2012;109(16):293\u20139.","journal-title":"Dtsch Arztebl Int"},{"issue":"4","key":"1074_CR26","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1093\/europace\/eus333","volume":"15","author":"T Wilke","year":"2013","unstructured":"Wilke T, Groth A, Mueller S, Pfannkuche M, Verheyen F, Linder R, et al. Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients. Europace. 2013;15(4):486\u201393.","journal-title":"Europace"},{"key":"1074_CR27","doi-asserted-by":"crossref","unstructured":"Asinger RW, Shroff GR, Simegn MA, Herzog CA. Anticoagulation for Nonvalvular atrial fibrillation: influence of epidemiologic trends and clinical practice patterns on risk stratification and net clinical benefit. Circ Cardiovasc Qual Outcomes. 2017;10(9).","DOI":"10.1161\/CIRCOUTCOMES.117.003669"},{"issue":"8","key":"1074_CR28","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1161\/STROKEAHA.117.017683","volume":"48","author":"I Hernandez","year":"2017","unstructured":"Hernandez I, Saba S, Zhang Y. Geographic variation in the use of oral anticoagulation therapy in stroke prevention in atrial fibrillation. Stroke. 2017;48(8):2289\u201391.","journal-title":"Stroke"},{"key":"1074_CR29","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ahj.2017.08.011","volume":"194","author":"BA Steinberg","year":"2017","unstructured":"Steinberg BA, Gao H, Shrader P, Pieper K, Thomas L, Camm AJ, et al. International trends in clinical characteristics and oral anticoagulation treatment for patients with atrial fibrillation: results from the GARFIELD-AF, ORBIT-AF I, and ORBIT-AF II registries. Am Heart J. 2017;194:132\u201340.","journal-title":"Am Heart J"},{"issue":"1","key":"1074_CR30","doi-asserted-by":"publisher","first-page":"6","DOI":"10.7326\/0003-4819-116-1-6","volume":"116","author":"Atrial Fibrillation Investigators","year":"1992","unstructured":"Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at risk. The stroke prevention in atrial fibrillation Investigators. Ann Intern Med. 1992;116(1):6\u201312.","journal-title":"Ann Intern Med"},{"issue":"12","key":"1074_CR31","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1001\/archinte.158.12.1316","volume":"158","author":"Atrial Fibrillation Investigators","year":"1998","unstructured":"Atrial Fibrillation Investigators. Echocardiographic predictors of stroke in patients with atrial fibrillation: a prospective study of 1066 patients from 3 clinical trials. Arch Intern Med. 1998;158(12):1316\u201320.","journal-title":"Arch Intern Med"},{"issue":"20","key":"1074_CR32","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1093\/eurheartj\/eht024","volume":"34","author":"Z Hijazi","year":"2013","unstructured":"Hijazi Z, Oldgren J, Siegbahn A, Granger CB, Wallentin L. Biomarkers in atrial fibrillation: a clinical review. Eur Heart J. 2013;34(20):1475\u201380.","journal-title":"Eur Heart J"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-019-1074-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12872-019-1074-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-019-1074-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T23:13:13Z","timestamp":1587510793000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-019-1074-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,23]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1074"],"URL":"https:\/\/doi.org\/10.1186\/s12872-019-1074-7","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,23]]},"assertion":[{"value":"26 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study is part of a project evaluating cardiovascular health care in the German State of Baden-Wuerttemberg and was approved by the ethics committee of the Faculty of Medicine of the Goethe-University Frankfurt (Main), Germany (reference number 291\/17). We obtained no individual consent of participants, because anonymized secondary data were used.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"94"}}